Successful tapering of dupilumab in atopic dermatitis with low disease activity: pragmatic daily practice study from the BioDay registry

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：II / II
页数：1
相关论文
共 38 条
  • [31] Sustained improvement in atopic dermatitis disease control and treatment satisfaction with dupilumab in clinical practice: 4-year follow-up results from the RELIEVE-AD study
    Wang, Zhixiao
    Yang, Min
    Chao, Jingdong
    Martins, Bruno
    Chuang, Chien-Chia
    Shumel, Brad
    Sierka, Debra
    Carboni, Margaret
    Strober, Bruce
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I63 - I64
  • [32] IMPROVEMENT IN DISEASE SEVERITY AND QUALITY OF LIFE IN PATIENTS WITH ATOPIC DERMATITIS TREATED WITH DUPILUMAB FOR UP TO 18 MONTHS: REAL-WORLD DATA FROM THE CANADIAN COHORT OF THE PROSE REGISTRY
    Lima, Hermenio
    Gooderham, Melinda J.
    Lynde, Charles W.
    Zhang, Haixin
    Daoud, Moataz
    Korotzer, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 37 - 37
  • [33] Treatment of adult patients with moderate-to-severe atopic dermatitis with dupilumab in early-phase clinical studies shows significant improvement in skin disease activity and pruritus: a review of study data
    Simpson, E.
    Beck, L.
    Thaci, D.
    Ardeleanu, M.
    Hamilton, J.
    Ren, H.
    Graham, N.
    Radin, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) : E14 - E14
  • [34] Dupilumab improves patient-reported outcomes among adults with moderate-to-severe atopic dermatitis (AD) in clinical practice: 30-36 month results from the RELIEVE-AD study
    Strober, Bruce
    Chao, Jingdong
    Chuang, Chien-Chia
    Yang, Min
    Shumel, Brad
    Wang, Jessie
    Bego-Le-Bagousse, Gaelle
    Sierka, Debra
    Wang, Zhixiao
    Delevry, Dimittri
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB159 - AB159
  • [35] A STUDY ON THE ACHIEVEMENT OF LUPUS LOW DISEASE ACTIVITY STATE AND QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: FROM THE JUNTENDO UNIVERSITY SLE PROSPECTIVE REGISTRY STUDY
    Matsushita, M.
    Amano, H.
    Nozawa, K.
    Ogasawara, M.
    Tada, K.
    Kempe, K.
    Kusaoi, M.
    Kawamoto, T.
    Minowa, K.
    Ando, S.
    Nemoto, T.
    Abe, Y.
    Hayashi, E.
    Murayama, G.
    Tsukahara, T.
    Yamanaka, K.
    Morimoto, S.
    Yang, K.
    Matsudaira, R.
    Katagiri, A.
    Nakiri, Y.
    Takasaki, Y.
    Yamaji, K.
    Tamura, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 669 - 670
  • [36] Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study
    Uhlig, Till
    Lie, Elisabeth
    Norvang, Vibeke
    Lexberg, Ase Stavland
    Rodevand, Erik
    Kroll, Frode
    Kalstad, Synove
    Olsen, Inge C.
    Kvien, Tore K.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (04) : 716 - 723
  • [37] BIOLOGIC FREE DISEASE CONTROL (BFDC) IN EARLY RA: PREDICTORS OF SUCCESSFUL WITHDRAWAL OF ADALIMUMAB (ADA) AFTER ACHIEVING STABLE LOW DISEASE ACTIVITY WITH ADA PLUS METHOTREXATE (MTX) - DATA FROM THE OPTIMA STUDY
    Smolen, J. S.
    Emery, P.
    Fleischmann, R.
    van Vollenhoven, R.
    Florentinus, S.
    Santra, S.
    Kupper, H.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 516 - 516
  • [38] Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study
    Takahashi, Nobunori
    Kojima, Toshihisa
    Kaneko, Atsushi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Kato, Takefumi
    Fukaya, Naoki
    Hayashi, Masatoshi
    Tsuboi, Seiji
    Kanayama, Yasuhide
    Funahashi, Koji
    Hanabayashi, Masahiro
    Hirabara, Shinya
    Asai, Shuji
    Yoshioka, Yutaka
    Ishiguro, Naoki
    RHEUMATOLOGY, 2015, 54 (05) : 854 - 859
1234